欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0845/002
药品名称
Marilamed
活性成分
Hydrochlorothiazide 25.0 mg
Ramipril 5.0 mg
剂型
Tablet
上市许可持有人
KRKA, d.d. Novo Mesto Smarjeska cesta 6 SL-8501 Novo Mesto Slovenia
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Poland (PL)
Ampril HD
Lithuania (LT)
Ampril HD 5 mg/25 mg tabletės
Estonia (EE)
Ampril HD 5 mg/25 mg tablets
Czechia (CZ)
Amprilan H 5 mg / 25 mg
Slovakia (SK)
AMPRIL HD
Slovenia (SI)
许可日期
2005/08/23
最近更新日期
2024/11/14
药物ATC编码
C09BA05 ramipril and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic [Article 10.1.(a)(iii), first paragraph]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Labeling005646_1
Date of last change:2024/09/06
Final PL
|
PRODUCT NAME_Ramipril _ Hydrochlorothiazide_tablets_ ___DK_Common QRD__SmPCPIL042456_3_clean
Date of last change:2024/09/06
Final Product Information
|
common_combined_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase